Professional Overview
Kenny Rankin is an accomplished pharmaceutical executive with over 30 years of experience in market access, distribution, and reimbursement strategy. As the Vice President of Market Access at Elevar Therapeutics, he leverages his deep industry expertise to drive commercial success for the company's innovative therapeutic solutions.
Experience Summary
Current Role
In his current role as Vice President of Market Access at Elevar Therapeutics, Kenny is responsible for shaping the company's market access strategies and ensuring seamless product commercialization. He works closely with payers, providers, and key stakeholders to secure favorable market positioning and optimized patient access for Elevar's portfolio.
Career Progression
Prior to joining Elevar, Kenny held several senior-level positions within the pharmaceutical industry, including Vice President of Market Access, Distribution & Reimbursement at CTI BioPharma, Sr. Director of National Accounts, Payer/Patient Access at Incyte, and various leadership roles at Eisai US and Sepracor. Throughout his career, he has consistently demonstrated the ability to drive strategic initiatives that enhance market access, optimize distribution, and improve patient outcomes.
Academic Background
Kenny holds a Bachelor of Science degree from the University of Cincinnati, where he specialized in Pharmaceutical Sciences.
Areas of Expertise
- Extensive experience in market access strategy, payer negotiations, and reimbursement optimization
- Proven track record of successfully launching and commercializing pharmaceutical products
- Expertise in navigating complex regulatory environments and managing government payer relationships
- Strong leadership skills, with the ability to build high-performing teams and drive cross-functional collaboration
Professional Impact
During his tenure at CTI BioPharma, Kenny spearheaded the successful market access and reimbursement strategy for a rare hematological cancer drug, resulting in improved patient access and a significant increase in product revenue. At Incyte, he led the development of innovative patient assistance programs that enhanced affordability and adherence, contributing to the company's overall commercial success.
Conclusion
With his deep industry expertise, strategic mindset, and proven track record of driving commercial success, Kenny Rankin is well-positioned to lead Elevar Therapeutics' market access initiatives and contribute to the company's continued growth and impact within the pharmaceutical industry.
